Wiem Lassoued

5PUBLICATIONS
33CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 12, 2026
Epigenetic plus cytokine therapy induces stem-like CD8+ T-cell reservoirs and intratumoral immune niches to overcome anti-PD-1 resistance.

|Dec 21, 2025
Society for Immunotherapy of Cancer: Standards for Reporting of Multiplex Immunohistochemistry/Immunofluorescence Assays (STORMI).

Sam Sater, Carlo B Bifulco, Jaime Rodriguez-Canales

|Jun 23, 2025
Programmed death-1 inhibition increases vaccine-induced T-cell infiltration in patients with prostate cancer.

Wiem Lassoued, Ravi A Madan, Elisabetta Xue

|May 02, 2025
Combination of HDAC inhibition and cytokine enhances therapeutic HPV vaccine therapy.

Lisa K Poppe, Nicholas Roller, Miriam Marlene Medina-Enriquez

|Nov 18, 2024
Adoptive transfer of membrane-restricted IL-12-TCR T cells promotes antigen spreading and elimination of antigen-negative tumor variants.

Ling Zhang, Scott M Norberg, Farrah Karimipour

Pageof 1

Frequent Collaborators

4 joint publications

James L Gulley

3 joint publications

Jeffrey Schlom

2 joint publications

Lisa K Poppe

2 joint publications

Daniel Burnett